These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29087990)

  • 1. Color Contrast in the Labeling of Preservative-Free Artificial Tears.
    Yellapu V; Wu G
    Eye Contact Lens; 2017 Nov; 43(6):411. PubMed ID: 29087990
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemicals in Preservative-Free Tears, Branded and Generic.
    Gao M; Wu G
    Eye Contact Lens; 2018 May; 44(3):203-204. PubMed ID: 29688955
    [No Abstract]   [Full Text] [Related]  

  • 3. Dry Eye Disease: An Update in 2022.
    Hakim FE; Farooq AV
    JAMA; 2022 Feb; 327(5):478-479. PubMed ID: 35103781
    [No Abstract]   [Full Text] [Related]  

  • 4. ASSESSMENT OF FUNCTIONAL CHANGES TEAR PRODUCTION UNDER THE ACTION OF THE EYE DROPS ON THE BASE OF NATURAL MOLECULE OF ECTOINE AND ARTIFICIAL TEARS IN PATIENTS WITH DRY EYE SYNDROME ON THE BACKGROUND OF ENDOCRINE OPHTHALMOPATHY.
    Veselovskaya NN; Zherebko IB
    Fiziol Zh (1994); 2016; 62(6):118-121. PubMed ID: 29762980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of new magistral method for the preparation of artificial tears].
    Kovács G; Varga D; Sebe I; Hajdú M; Szabó P; Ostorházi E; Antal I
    Acta Pharm Hung; 2015; 85(4):139-43. PubMed ID: 26964402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.
    Safarzadeh M; Azizzadeh P; Akbarshahi P
    J Optom; 2017; 10(4):258-264. PubMed ID: 27989693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
    Jee D; Park M; Lee HJ; Kim MS; Kim EC
    J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous anti-glaucoma drug therapy as a risk factor of dry eye].
    Erichev VP; Petrov SY; Volzhanin AV; Ghazaryan SA
    Vestn Oftalmol; 2019; 135(6):117-123. PubMed ID: 32015316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflection on tears and treatments.
    Foulks GN
    Ocul Surf; 2008 Oct; 6(4):151. PubMed ID: 18827946
    [No Abstract]   [Full Text] [Related]  

  • 11. Over the counter (OTC) artificial tear drops for dry eye syndrome: A Cochrane review summary.
    van der Westhuizen L; Pucker AD
    Int J Nurs Stud; 2017 Jun; 71():153-154. PubMed ID: 28237389
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction.
    Albietz JM; Schmid KL
    Clin Exp Optom; 2017 Nov; 100(6):603-615. PubMed ID: 28585260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of modification of the osmolarity in graft versus host disease.
    García-Delpech S; Hervás Ontiveros A; Soler M; Udaondo P; Cisneros-Lanuza Á
    Arch Soc Esp Oftalmol; 2015 Aug; 90(8):401-2. PubMed ID: 25817964
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease.
    Pinto-Fraga J; López-de la Rosa A; Blázquez Arauzo F; Urbano Rodríguez R; González-García MJ
    Eye Contact Lens; 2017 Jan; 43(1):57-63. PubMed ID: 26783978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of various lubricant eye drops on the in vitro rabbit corneal healing and toxicity.
    Dutescu RM; Panfil C; Schrage N
    Exp Toxicol Pathol; 2017 Mar; 69(3):123-129. PubMed ID: 27989569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye after laser in-situ keratomileusis.
    Raoof D; Pineda R
    Semin Ophthalmol; 2014; 29(5-6):358-62. PubMed ID: 25325861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Rare Danger of Presumably Benign Artificial Tears.
    Prescott CR; Colby KA
    JAMA Ophthalmol; 2023 May; 141(5):497-498. PubMed ID: 36947074
    [No Abstract]   [Full Text] [Related]  

  • 20. Infections from Over-the-Counter Artificial Tears: Implications for Patients and Clinicians.
    Novack GD
    Ophthalmology; 2023 Nov; 130(11):1114-1117. PubMed ID: 37865500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.